KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) EBT Margin: 2015-2025

Historic EBT Margin for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to 21.64%.

  • Medpace Holdings' EBT Margin fell 63.00% to 21.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.02%, marking a year-over-year increase of 113.00%. This contributed to the annual value of 22.57% for FY2024, which is 477.00% up from last year.
  • Latest data reveals that Medpace Holdings reported EBT Margin of 21.64% as of Q3 2025, which was up 4.86% from 20.64% recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' EBT Margin peaked at 24.95% during Q4 2024, and registered a low of 15.34% during Q2 2021.
  • Over the past 3 years, Medpace Holdings' median EBT Margin value was 20.92% (recorded in 2024), while the average stood at 20.45%.
  • As far as peak fluctuations go, Medpace Holdings' EBT Margin tumbled by 445bps in 2023, and later surged by 675bps in 2024.
  • Quarterly analysis of 5 years shows Medpace Holdings' EBT Margin stood at 18.12% in 2021, then spiked by 56bps to 18.69% in 2022, then crashed by 49bps to 18.20% in 2023, then surged by 675bps to 24.95% in 2024, then crashed by 63bps to 21.64% in 2025.
  • Its EBT Margin stands at 21.64% for Q3 2025, versus 20.64% for Q2 2025 and 21.16% for Q1 2025.